What is the dose of Vigabatrin?

The dosage of Vigabatrin varies depending on the patient's age, condition and treatment needs. The appropriate dosage is usually determined by the doctor based on the individual situation. The following are common dosage guidelines, but specific dosage should be determined after evaluation by a professional physician.

For the treatment of infantile spasms, a starting dose of Vigabatrin is usually recommended at 50mg/kg body weight per day, divided into two doses. The dose can be gradually increased according to the condition of the disease, usually not exceeding 150 mg/kg body weight per day. For infant patients, starting at a low dose and increasing slowly can help reduce the risk of side effects.

The usual starting dose for adult patients is 1,000 mg daily, taken in two divided doses. If it doesn't work, your doctor may gradually increase the dose over several weeks, usually to a maximum of 3,000 milligrams per day. Adult patients need to be closely monitored for the emergence of side effects, especially changes in vision.

The starting dose for pediatric patients is 40-50mg/kg body weight per day, also taken in two divided doses. Depending on the patient's response to the drug and side effects, the dose may be increased, but usually does not exceed 150 mg/kg body weight per day. When pediatric patients are taking Vigabatrin, doctors will perform regular vision exams to avoid long-term vision damage.

When taking Vigabatrin, it is recommended to take it after a meal to reduce gastrointestinal discomfort. In addition, because Vigabatrin may have adverse effects on vision, patients should undergo regular eye examinations during treatment so that any vision changes can be detected at an early stage and treated promptly.

In short, the dose of Vigabatrin varies from person to person, and doctors will develop a personalized treatment plan based on the patient's age, type of condition, and tolerance to the drug. Do not adjust the dosage or stop medication at will to ensure therapeutic effect and medication safety.